Sanofi-Aventis Wants F.D.A. to Reconsider Heart Drug
May 15th, 2008 at 7:08 pm (Drugs (Pharmaceuticals), Food and Drug Administration, Heart, Regulation and Deregulation of Industry, Sanofi-Aventis|SNY|NYSE)
The company said it would resubmit its application for Multaq based on results from a study showing that the drug reduced both hospitalization and death in patients with atrial fibrillation.
Zrodlo (oryginalny wpis) na http://www.nytimes.com/2008/05/16/business/16drug.html?partner=rssnyt&emc=rss,By STEPHANIE SAUL